In MPTP-induced PD mouse models, TFA administration via gavage increased the expression of SLC7A11 and GPX4, raised the GSH/GSSG ratio, enhanced cellular antioxidant capacity, and inhibited neuronal ferroptosis [118]. Here, SLC7A11 is linked to Parkinson disease.